United States Nuclear Imaging Equipment Market Growth | Radiopharmaceutical Advancements Enhance Imaging Accuracy | anon Medical Systems Corp, Serac Imaging Systems Ltd, Neusoft Medical Systems Co Ltd., DIGIRAD HEALTH, INC., Mediso Ltd

DataM Intelligence unveils its latest report on the "Nuclear Imaging Equipment Market Size 2025," offering an in-depth analysis of market trends, growth drivers, competitive landscape, and regional dynamics. The study covers market size in value and volume, CAGR forecasts, and emerging opportunities that can guide businesses in seizing growth potential and crafting winning strategies. Packed with data-driven insights on current developments and future trends, this report is essential for companies aiming to stay ahead in the competitive Market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/nuclear-imaging-equipment-market?kb

Latest M&A in Nuclear Imaging Equipment

Lantheus acquired Life Molecular Imaging in a $750 million deal to expand its portfolio of PET tracers for Alzheimer's and oncology imaging, strengthening its nuclear diagnostics pipeline.

Algernon acquired NoBrainer Imaging Centers to develop Alzheimer's-focused diagnostic clinics using PET imaging of amyloid and tau proteins.

RadNet acquired Singapore-based AI imaging company SeeMode Technologies to incorporate automated vascular imaging into its services.

GE HealthCare announced an agreement to acquire icometrix, a developer of AI-powered brain MRI analysis tools, enhancing its neuroimaging portfolio.

The nuclear imaging sector is marked by targeted acquisitions to expand molecular imaging capabilities and integrate AI analytics.

List of Top Key Player:

Siemens Healthcare GmbH, GE Healthcare, Philips Healthcare, Canon Medical Systems Corp, Serac Imaging Systems Ltd, Neusoft Medical Systems Co Ltd., DIGIRAD HEALTH, INC., Mediso Ltd., PerkinElmer, and MILabs B.V.

Latest News & Market Trends

The global nuclear imaging devices market was valued at approximately $3.2-3.85 billion in 2024-2025, expected to grow to about $5-5.1 billion by 2034-2035 at a CAGR of ~5-5.6%.

Growth drivers include rising chronic diseases, demand for early and precise diagnosis, advances in hybrid imaging (PET/CT, SPECT/CT), and increased use of radiopharmaceuticals.

AI is transforming nuclear medicine with improved image reconstruction, diagnostic accuracy, and workflow automation.

Asia-Pacific is a key growth region, with China notably expanding nuclear imaging agent production and adoption.

Forecast Projection:

The Global Nuclear Imaging Equipment Market is poised for significant growth between 2025 and 2032. In 2024, the market maintained a steady upward trajectory, and with strategic initiatives by leading players accelerating adoption, the market is expected to soar throughout the forecast period. Companies leveraging these trends are well-positioned to capture emerging opportunities and maximize revenue potential.

Market Intelligence Research Process:

The Nuclear Imaging Equipment Market research report by DataM Intelligence combines primary and secondary data to deliver deep, actionable insights. It examines the full spectrum of factors shaping the industry, from government regulations and market conditions to competitive dynamics, historical trends, technological breakthroughs, upcoming innovations, and potential challenges. This comprehensive analysis not only highlights growth prospects but also identifies barriers, equipping businesses to navigate market volatility and capitalize on emerging opportunities.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @ https://www.datamintelligence.com/buy-now-page?report=nuclear-imaging-equipment-market?kb

Key Segmentation:

By Product: (Positron Emission Tomography (PET) Systems, Positron Emission Tomography/Computed Tomography (PET/CT) Systems, Positron Emission Tomography/Magnetic Resonance Imaging (PET/MRI) Systems, Single Photon Emission Computed Tomography (SPECT) Systems, Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) Systems)

By Application: (Oncology, Cardiology, Neurology, Others)

By End-users: (Hospitals, Imaging Centers, Academic & Research Centers, Others)

Global Growth Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Latest FDA Approvals

FDA approved an increasing number of radiopharmaceuticals for oncologic and neurologic indications, including PET and SPECT imaging agents that enable early detection and personalized treatment planning.

Regulatory guidances on 3D printed drugs and diagnostic imaging agents support innovation and patient access.

New approvals include advanced tracers targeting prostate cancer, neurodegenerative diseases, and cardiology applications.

Benefits of the Report:

Chapter 1 - Market Overview: Kickstarts the report with a comprehensive snapshot of the Nuclear Imaging Equipment Market, summarizing key segments by region, product type, and application. Highlights include market size, segment growth potential, and short- & long-term industry outlook.

Chapter 2 - Emerging Trends: Uncovers the game-changing trends and high-impact innovations shaping the future of the industry.

Chapter 3 - Competitive Landscape: Offers a deep dive into market competition, detailing revenue shares, strategic initiatives, and recent mergers & acquisitions.

Chapter 4 - Top Player Profiles: Features detailed company profiles, covering revenue, profit margins, product lines, and major milestones for leading market players.

Chapters 5 & 6 - Regional & Country Analysis: Breaks down revenue performance across global regions, providing insights on market sizes, opportunities, and growth prospects worldwide.

Chapter 7 - Segmentation Analysis: Explores market segmentation by type, revealing high-potential categories and guiding businesses towards lucrative areas.

Chapter 8 - Application Insights: Examines downstream markets and identifies promising sectors for expansion, showing how different applications are driving growth.

Chapter 9 - Supply Chain Mapping: Maps the entire industry supply chain, highlighting upstream and downstream activities for a holistic market perspective.

Chapter 10 - Key Takeaways: Concludes with critical insights and actionable strategies, equipping stakeholders to make informed decisions and stay ahead in the market.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/nuclear-imaging-equipment-market?kb

Reimbursement Updates

CMS revised nuclear medicine reimbursement policies effective January 2025 to unbundle and separately pay for expensive diagnostic radiopharmaceuticals over $630 per dose.

This change removes a major barrier to patient access, encouraging wider use of nuclear imaging scans in hospitals and clinics.

Reimbursements now better reflect the costs of advanced scans such as PET and SPECT, improving sustainability for providers and manufacturers.

Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/nuclear-imaging-equipment-market?kb

Drugs Related to Nuclear Imaging Equipment

Radiopharmaceuticals such as technetium-99m (Tc-99m) remain widely used for diagnostics, involved in about 80% of nuclear medicine procedures.

Therapeutic radiopharmaceuticals emitting alpha or beta particles (e.g., radium-223 for bone metastases) are gaining attention for cancer treatment.

Emerging targeted alpha therapies and radiolabeled antibodies use nuclear imaging for both diagnosis and treatment monitoring.

Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.